RxSight (RXST) Gross Margin (2020 - 2026)
RxSight (RXST) posted Gross Margin of 76.06% for Q1 2026, down 1.82% on a QoQ basis from 77.47% in Q4 2025, and up 131.0% year-over-year from 32.93% in Q1 2025.
RxSight (RXST) Gross Margin (2020 - 2026) Analysis & Trends
RxSight's Gross Margin history runs 7 years deep, the most recent figure standing at 76.06% for Q1 2026.
- Quarterly Gross Margin rose 131.0% year-over-year to 76.06% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 77.02% (up 515.0% YoY) and the FY2025 annual result came in at 76.6%, up 589.0% from the prior year.
- Gross Margin was 76.06% for Q1 2026 at RxSight, down from 77.47% in the prior quarter.
- Across five years, Gross Margin topped out at 79.85% in Q3 2025 and bottomed at 42.06% in Q1 2022.
- A 5-year average of 63.47% and a median of 69.51% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin jumped 5873 bps — and 2026, when it surged 131 bps.
- RxSight's Gross Margin stood at 46.13% in 2022, then soared by 34 bps to 61.77% in 2023, then grew by 16 bps to 71.59% in 2024, then grew by 8 bps to 77.47% in 2025, then fell by 2 bps to 76.06% in 2026.
- Business Quant data shows RXST's Gross Margin at 76.06% in Q1 2026, 77.47% in Q4 2025, and 79.85% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | 76.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.06% |
| Dec 31, 2025 | 77.47% |
| Sep 30, 2025 | 79.85% |
| Jun 30, 2025 | 74.89% |
| Mar 31, 2025 | 74.76% |
| Dec 31, 2024 | 71.59% |
| Sep 30, 2024 | 71.42% |
| Jun 30, 2024 | 69.51% |
| Mar 31, 2024 | 70.09% |
| Dec 31, 2023 | 61.77% |
| Sep 30, 2023 | 61.85% |
| Jun 30, 2023 | 57.74% |
| Mar 31, 2023 | 59.27% |
| Dec 31, 2022 | 46.13% |
| Sep 30, 2022 | 42.46% |
| Jun 30, 2022 | 42.15% |
| Mar 31, 2022 | 42.06% |
| Dec 31, 2021 | 34.05% |
| Sep 30, 2021 | 23.18% |
| Jun 30, 2021 | -16.58% |